~~<i id='D5B439BC12'><strike id='D5B439BC12'><tt id='D5B439BC12'><pre id='D5B439BC12'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：entertainment 2025-09-30 14:53:33 - browse：4

JOHNSON & JOHNSON HEADQUARTERS — Daniel Hulshizer/AP

Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease.

To sharpen that focus, R&D chief John Reed told STAT that the company is de-emphasizing two areas that have been mainstays for the drug and medical device giant: infectious disease and vaccines, as well as medicines targeting kidney disease and rare eye conditions.

The disclosures were made in an interview ahead of an investor meeting Reed is leading Tuesday aimed at generating excitement about the company’s research and development efforts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： FDA approves Recor Medical high blood pressure device

focus

leisure time

hotspot

leisure time

focus

MollyFerguson/STATMoonLakeImmunotherapeutics,aSwissbiotech,wasburiedMondayunderanavalancheofitsownda

WSS

FDA approves potent Eli Lilly obesity drug, Zepbound

More doctors should go into startup world

My daughter's legacy lives on through her writing, phage therapy

Ambulance rides for just $100? Advisers want major billing fixes

Curing rare childhood diseases will falter unless Congress steps up

California wildfire smoke linked to 52,000 early deaths, study says

focus

focus

focus

Guidelines to prevent youth baseball injuries need more muscle

Free speech concerns arise in wake of journal editor Eisen's firing

Dobbs anniversary: the lost opportunity of abortion as health care

A clever new way to fix Medicaid and graduate medical education

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare solvency divides Republicans at the presidential debate

https://cbu01.alicdn.com/img/ibank/2015/870/178/2103871078_1196197040.220x220xz.jpg

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Extreme heat events are a public health emergency

leisure time

Medicare solvency divides Republicans at the presidential debate

Statins may not be needed by millions of people, study suggests

The new shift in health care is toward less care

White House calls on federal agencies to crack down on AI abuses

'Essentially witchcraft:' A former naturopath takes on the field

How faith leaders like me can help address America's obesity epidemic

hotspot

hotspot

leisure time

focus